Department of Pharmacology & Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
Department of Biological Science, Florida State University, Tallahassee, FL 32306, USA.
Genomics Proteomics Bioinformatics. 2021 Feb;19(1):108-122. doi: 10.1016/j.gpb.2020.06.016. Epub 2021 Feb 19.
The Zika virus (ZIKV) and dengue virus (DENV) flaviviruses exhibit similar replicative processes but have distinct clinical outcomes. A systematic understanding of virus-host protein-protein interaction networks can reveal cellular pathways critical to viral replication and disease pathogenesis. Here we employed three independent systems biology approaches toward this goal. First, protein array analysis of direct interactions between individual ZIKV/DENV viral proteins and 20,240 human proteins revealed multiple conserved cellular pathways and protein complexes, including proteasome complexes. Second, an RNAi screen of 10,415 druggable genes identified the host proteins required for ZIKV infection and uncovered that proteasome proteins were crucial in this process. Third, high-throughput screening of 6016 bioactive compounds for ZIKV inhibition yielded 134 effective compounds, including six proteasome inhibitors that suppress both ZIKV and DENV replication. Integrative analyses of these orthogonal datasets pinpoint proteasomes as critical host machinery for ZIKV/DENV replication. Our study provides multi-omics datasets for further studies of flavivirus-host interactions, disease pathogenesis, and new drug targets.
寨卡病毒(ZIKV)和登革热病毒(DENV)黄病毒表现出相似的复制过程,但具有不同的临床结果。系统地了解病毒-宿主蛋白-蛋白相互作用网络可以揭示对病毒复制和疾病发病机制至关重要的细胞途径。在这里,我们采用了三种独立的系统生物学方法来实现这一目标。首先,对单个 ZIKV/DENV 病毒蛋白与 20240 个人类蛋白之间的直接相互作用进行蛋白质芯片分析,揭示了多个保守的细胞途径和蛋白质复合物,包括蛋白酶体复合物。其次,对 10415 个可用药基因进行 RNAi 筛选,确定了 ZIKV 感染所需的宿主蛋白,并发现蛋白酶体蛋白在这一过程中至关重要。第三,对 6016 种生物活性化合物进行高通量筛选以抑制 ZIKV,得到了 134 种有效化合物,其中包括 6 种蛋白酶体抑制剂,它们既能抑制 ZIKV 又能抑制 DENV 的复制。这些正交数据集的综合分析将蛋白酶体确定为 ZIKV/DENV 复制的关键宿主机制。我们的研究提供了多组学数据集,可进一步研究黄病毒-宿主相互作用、疾病发病机制和新的药物靶点。